113 related articles for article (PubMed ID: 6152530)
21. [Components of complement in patients with immediate hypersensitivity].
Anania A; Massobrio AM; Cascio B; Bosso E; Cascio G
Minerva Med; 1998 Mar; 89(3):77-81. PubMed ID: 9575333
[TBL] [Abstract][Full Text] [Related]
22. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
Molenaar ET; Voskuyl AE; Familian A; van Mierlo GJ; Dijkmans BA; Hack CE
Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
[TBL] [Abstract][Full Text] [Related]
23. Serum complement level in dengue hemorrhagic fever.
Nishioka K
Allerg Immunol (Leipz); 1974-1975; 20-21(4):385-92. PubMed ID: 4283486
[TBL] [Abstract][Full Text] [Related]
24. Classical pathway complement activity in schizophrenia.
Hakobyan S; Boyajyan A; Sim RB
Neurosci Lett; 2005 Feb; 374(1):35-7. PubMed ID: 15631892
[TBL] [Abstract][Full Text] [Related]
25. Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation.
Dernellis J; Panaretou M
Am J Cardiol; 2006 Jan; 97(2):245-8. PubMed ID: 16442371
[TBL] [Abstract][Full Text] [Related]
26. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
Low PJ; Ai R; Ogata RT
J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
[TBL] [Abstract][Full Text] [Related]
27. Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine.
Goenka MK; Kochhar R; Tandia B; Mehta SK
Am J Gastroenterol; 1996 May; 91(5):917-21. PubMed ID: 8633581
[TBL] [Abstract][Full Text] [Related]
28. [Immunological study in sickle cell disease patients: importance of the complement system].
Sassi F; Bardi R; Neji T; Ayed K; Ben Dridi MF
Tunis Med; 2003 Mar; 81(3):195-9. PubMed ID: 12793071
[TBL] [Abstract][Full Text] [Related]
29. Serum complement levels in patients with cancer of the uterine cervix before and after radiation therapy.
Pulay AT; Füst G; Csömör A
Neoplasma; 1980; 27(2):211-6. PubMed ID: 7393359
[TBL] [Abstract][Full Text] [Related]
30. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
31. [Levels of complement components in plasma of onco-hematologic patients with defective hemopoiesis].
Rybakova LP; Tiagotin IV; Ganapiev AA; Moiseev SI; Ushakova EA; Abdulkadyrov KM; Ishchenko AM
Vopr Onkol; 1996; 42(2):63-7. PubMed ID: 8815636
[TBL] [Abstract][Full Text] [Related]
32. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis.
Holt PJ; Davies MG; Saunders KC; Nuki G
Medicine (Baltimore); 1980 Mar; 59(2):114-33. PubMed ID: 7360040
[TBL] [Abstract][Full Text] [Related]
33. Complement activation in acute coronary syndromes.
Iltumur K; Karabulut A; Toprak G; Toprak N
APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
[TBL] [Abstract][Full Text] [Related]
34. Proceedings: Serum complement components C3 and C4 in inflammatory bowel disease.
Ward M; Eastwood MA
Gut; 1974 Oct; 15(10):835. PubMed ID: 4215646
[No Abstract] [Full Text] [Related]
35. Humoral immune system in inflammatory bowel disease: I. Complement levels.
Hodgson HJ; Potter BJ; Jewell DP
Gut; 1977 Sep; 18(9):749-53. PubMed ID: 604196
[TBL] [Abstract][Full Text] [Related]
36. [Serum complement levels in ulcerative colitis].
Díaz-Rubio García M; Díaz-Rubio García E; Candel Monserrate I; Erroz Serrano A
Rev Clin Esp; 1980 Feb; 156(4):241-3. PubMed ID: 7394204
[No Abstract] [Full Text] [Related]
37. Complement localization in ischemic baboon myocardium.
McManus LM; Kolb WP; Crawford MH; O'Rourke RA; Grover FL; Pinckard RN
Lab Invest; 1983 Apr; 48(4):436-47. PubMed ID: 6339810
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro.
Rubinstein A; Das KM; Melamed J; Murphy RA
Clin Exp Immunol; 1978 Aug; 33(2):217-24. PubMed ID: 31252
[TBL] [Abstract][Full Text] [Related]
39. How do complement components and fragments affect cellular immunological function?
Gelfand JA
J Trauma; 1984 Sep; 24(9 Suppl):S118-24. PubMed ID: 6332921
[No Abstract] [Full Text] [Related]
40. The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) protein.
Feinstein PA; Kaplan SR; Thayer WR
Gastroenterology; 1976 Feb; 70(2):181-5. PubMed ID: 2509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
